Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

838
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
838
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study on the Inhibitory Effects of Naringenin-Loaded Nanostructured Lipid Carriers Against Nonalcoholic Fatty Liver Disease.

Journal of biomedical nanotechnology·2021
Same author

Designing Zn-doped nickel sulfide catalysts with an optimized electronic structure for enhanced hydrogen evolution reaction.

Nanoscale·2021
Same author

Clinical characteristics of low-grade tumor-related epilepsy and its predictors for surgical outcome.

Annals of clinical and translational neurology·2021
Same author

Switching Spinless and Spinful Topological Phases with Projective PT Symmetry.

Physical review letters·2021
Same author

Comparison of Duration of Response vs Conventional Response Rates and Progression-Free Survival as Efficacy End Points in Simulated Immuno-oncology Clinical Trials.

JAMA network open·2021
Same author

Polyphyllin Ⅲ-Induced Ferroptosis in MDA-MB-231 Triple-Negative Breast Cancer Cells can Be Protected Against by KLF4-Mediated Upregulation of xCT.

Frontiers in pharmacology·2021
Same journal

Dietary glycemic index/glycemic load and knee osteoarthritis: associations with inflammation and oxidative stress.

Biomarkers in medicine·2026
Same journal

Prognostic value of the CALLY index in patients undergoing transcatheter aortic valve implantation.

Biomarkers in medicine·2026
Same journal

The relationship between serum neopterin levels and disease activity in patients with spondyloarthropathy.

Biomarkers in medicine·2026
Same journal

Prognostic and clinicopathological role of fibrinogen-to-albumin ratio in biliary tract cancers: a meta-analysis.

Biomarkers in medicine·2026
Same journal

Septin9 gene methylation in plasma for gastric cancer detection: a systematic review and meta-analysis.

Biomarkers in medicine·2026
Same journal

Association between ABO blood groups and gastric cancer outcomes: a Kaplan-Meier-derived patient data meta-analysis.

Biomarkers in medicine·2026
See all related articles

Related Experiment Video

Updated: Apr 4, 2026

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.7K

Translating predictive biomarkers within oncology clinical development programs.

Robert A Beckman1, Cong Chen2

  • 1Departments of Oncology & Biostatistics, Bioinformatics & Biomathematics, Lombardi Comprehensive Cancer Center & Innovation Center for Biomedical Informatics, Georgetown University Medical Center, 4000 Reservoir Road NW, Suite 120 Washington, DC 20007, USA.

Biomarkers in Medicine
|September 3, 2015
PubMed
Summary
This summary is machine-generated.

This review introduces a framework for managing predictive biomarker risks in cancer therapy development. It offers methods for adaptive decision-making to maximize benefits and optimize drug development efficiency.

Keywords:
benefit–cost ratiodecision analysisoptimizationpredictive biomarker

More Related Videos

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

18.8K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

6.1K

Related Experiment Videos

Last Updated: Apr 4, 2026

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.7K
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

18.8K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

6.1K

Area of Science:

  • Oncology
  • Translational Medicine
  • Biostatistics

Background:

  • Predictive biomarkers are crucial for personalized medicine and improving cancer therapy efficacy.
  • The performance of predictive biomarkers can be variable, necessitating risk management strategies.

Purpose of the Study:

  • To provide a framework for managing the risks associated with predictive biomarkers.
  • To outline methods for maximizing the benefits derived from predictive biomarkers.
  • To present techniques for optimizing the efficiency of drug development.

Main Methods:

  • Development of a data-driven, adaptive decision-making framework for biomarker use.
  • Application of methods to clinical development based on data validation.
  • Presentation of techniques for optimizing development efficiency metrics.

Main Results:

  • The proposed framework enables adaptive management of predictive biomarker risks.
  • Methods facilitate data-driven decisions throughout clinical development.
  • Techniques are presented to enhance overall drug development efficiency.

Conclusions:

  • Effective management of predictive biomarkers is essential for realizing the full potential of personalized cancer medicine.
  • Adaptive, data-driven strategies can mitigate risks and improve the value of predictive biomarkers.
  • Optimizing development efficiency through biomarker management can lead to more successful drug indications.